Evidence map›Paper›PMID 36232701›Full record

ArticleInternational journal of molecular sciences2022

SP1 and NFY Regulate the Expression of

Ignacio Ventura, Fernando Revert, Francisco Revert-Ros, Lucía Gómez-Tatay, Jesús A Prieto-Ruiz, José Miguel Hernández-Andreu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ignacio VenturaGrupo de Investigación en Medicina Molecular y Mitocondrial, Universidad Católica de Valencia 'San Vicente Mártir', 46001 Valencia, Spain.ORCID 0000-0001-6426-2999
Fernando RevertGrupo de Investigación en Medicina Molecular y Mitocondrial, Universidad Católica de Valencia 'San Vicente Mártir', 46001 Valencia, Spain.ORCID 0000-0002-7304-5846
Francisco Revert-RosGrupo de Investigación en Medicina Molecular y Mitocondrial, Universidad Católica de Valencia 'San Vicente Mártir', 46001 Valencia, Spain.ORCID 0000-0002-6162-3370
Lucía Gómez-TatayGrupo de Investigación en Medicina Molecular y Mitocondrial, Universidad Católica de Valencia 'San Vicente Mártir', 46001 Valencia, Spain.ORCID 0000-0003-3478-9436
Jesús A Prieto-RuizGrupo de Investigación en Medicina Molecular y Mitocondrial, Universidad Católica de Valencia 'San Vicente Mártir', 46001 Valencia, Spain.ORCID 0000-0003-2726-7963
José Miguel Hernández-AndreuGrupo de Investigación en Medicina Molecular y Mitocondrial, Universidad Católica de Valencia 'San Vicente Mártir', 46001 Valencia, Spain.
Valencia Catholic University Saint Vincent Martyr · ES

Funding

Generalitat Valenciana GV/2020/179
6 · The paper itself

Abstract

The Polyribonucleotide nucleotidyltransferase 1 gene (

Indexed as

CCAAT-Binding FactorExoribonucleasesLiver NeoplasmsMitochondrial ProteinsPolyribonucleotide NucleotidyltransferaseSp1 Transcription FactorBinding SitesHumansLuciferasesNeoplasmsRNA, MessengerRNA, MitochondrialRNA, Small InterferingCCAAT-Binding FactorExoribonucleasesLuciferasesMitochondrial Proteinsnuclear factor YPNPT1 protein, humanPolyribonucleotide NucleotidyltransferaseRNA, MessengerRNA, MitochondrialRNA, Small InterferingSP1 protein, humanSp1 Transcription Factorliver cancermitochondriaNFYAPNPT1SP1

Identifiers

PMID36232701
PMCPMC9570217
OpenAlexW4297539436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.